Previous Article | Next Article ![]()
Infection and Immunity, September 2001, p. 5529-5537, Vol. 69, No. 9
Pathogénie Bactérienne
Intestinale, Laboratoire de Bactériologie, Université
d'Auvergne, 63001 Clermont-Ferrand,1 and
Laboratoire de Recherche sur les Maladies Inflammatoires de
l'Intestin, Centre Hospitalier Universitaire, 59000 Lille,2 France
Received 15 March 2001/Returned for modification 9 April
2001/Accepted 11 June 2001
Escherichia coli strains recovered from Crohn's
disease (CD) lesions are able to adhere to and invade cultured
intestinal epithelial cells. We analyzed the behavior within
macrophages of adherent invasive E. coli (AIEC) strains
isolated from patients with CD. All the 15 AIEC strains tested were
able to replicate extensively within J774-A1 cells: the numbers of
intracellular bacteria increased 2.2- to 74.2-fold at 48 h over
that at 1 h postinfection. By use of murine peritoneal macrophages
and human monocyte-derived-macrophages, the reference AIEC strain LF82
was confirmed to be able to survive intracellularly. Transmission electron micrographs of AIEC LF82-infected macrophages showed that at
24 h postinfection, infected cells harbored large vacuoles containing numerous bacteria, as a result of the fusion of several vacuoles occurring after 8 h postinfection. No lactate dehydrogenase (LDH) release, no sign of DNA fragmentation or degradation, and no
binding to fluorescein isothlocyanate-labeled annexin V were observed
with LF82-infected J774-A1 cells, even after 24 h postinfection. LF82-infected J774-A1 cells secreted 2.7-fold more tumor necrosis factor alpha (TNF- Crohn's disease (CD) is an
inflammatory bowel disease characterized by a chronic transmural,
segmental, and typically granulomatous inflammation of the intestine in
humans. CD lesions develop from an accumulation of lymphocytes and
plasma cells, followed by an influx of macrophages, which transform
into epithelioid cells and generate nascent granulomas (for a review
see reference 12).
The etiology of CD is still unknown. The general concept is that CD
pathogenesis is immunologically mediated and greatly influenced by
genetic, environmental, and other endogenous host factors. Infectious
agents as a possible environmental cause of CD have been investigated
since the disease was first recognized. Some characteristic pathologic
elements of CD, including aphthous ulcers of the mucosa, mural
abscesses, and macrophage and epithelioid cell granulomas, occur in
well-recognized infectious diseases, like shigellosis, salmonellosis,
and yersinial enterocolitis, in which invasiveness is an essential
virulence factor of the bacteria involved (for a review see reference
40).
We previously showed that Escherichia coli is abnormally
predominant (between 50 and 100% of the total number of aerobes and anaerobes) in early and chronic ileal lesions of CD and that a great
majority of the E. coli strains isolated from Crohn's ileal mucosa adhere strongly in vitro to intestinal epithelial cells (11). The latter property could enable the bacteria to
colonize the intestinal mucosa. Qualitative and quantitative analysis
of E. coli strain LF82 isolated from a chronic ileal lesion
of a patient with CD revealed that it is a true invasive pathogen
(6). It efficiently invades a wide range of human
epithelial cell lines in vitro, including HEp-2 cells and the
intestinal cells Intestine-407, Caco-2, and HCT-8. In contrast with
most invasive bacteria belonging to the Enterobactericeae
family, its uptake is dependent upon both functioning host cell actin
microfilaments and microtubules. It survives and replicates in the host
cell cytoplasm after lysis of the endocytic vacuole. Electron
microscope examination of LF82-infected epithelial cells revealed a
macropinocytosis-like process of entry, characterized by the elongation
of membrane extensions which surrounded the bacteria at the sites of
contact between the entering bacteria and the epithelial cells
(5). The invasive process was found to be original in that
LF82 possessed none of the known genetic invasive determinants
described for enteroinvasive, enteropathogenic, or enterotoxigenic
E. coli, or Shigella flexneri, i.e., the
ipaC plasmid gene encoding the invasin of S. flexneri, and enteroinvasive E. coli (EIEC), the
eae gene encoding the intimin of enteropathogenic E. coli (EPEC), and the tia gene encoding a 25-kDa outer
membrane protein involved in enterotoxigenic E. coli (ETEC)
invasiveness (6, 7). Recent data have revealed a high
prevalence of invasive strains associated with the ileal mucosa of
patients with CD compared to that for controls, supporting a putative
role of E. coli invasiveness in the pathogenesis of CD
(7, 29). Characterization of these strains revealed that
they shared the same mechanism of entry as LF82 and that they lacked
any of the invasive genetic determinants described above. They were
thus clustered in a new potentially pathogenic group of invasive
E. coli, which we designate AIEC for adherent invasive
E. coli (6, 7).
In CD mucosa the numbers of macrophages and antigen-presenting
dendritic cells are increased (37). Macrophages residing in the intestine or attracted to the site of inflammation might normally serve as a first line of defense by nonspecifically
eliminating microorganisms that have penetrated from the intestinal
lumen. Invasive bacteria have developed various strategies to
counteract these mechanisms, which, when successful, enable them to
survive and multiply and sometimes to destroy macrophages (for
reviews see references 1, 13, 16, and 31). The behavior of
the microorganisms within macrophages and host responses are
key components in the replication and perpetuation of these intestinal
pathogens. Elicitation of an inflammatory cascade may either eliminate
the invading bacteria or facilitate further bacterial invasion
(33, 34, 42).
As interactions between bacteria and macrophages dictate the
outcome of most of the infectious diseases, the aim of the present work
was to analyze the behavior within macrophages of AIEC strains isolated from patients with CD. Three different types of
macrophages were used: the universally used J774-A1 murine
macrophage-like cell line, which allowed us to compare the
behavior of AIEC with other invasive bacteria studied so far, murine
peritoneal macrophages, and human monocyte-derived
macrophages (HMDM). The survival and replication of the
phagocytosed bacteria were studied, as well as the behavior of the
infected macrophages, by analyzing the synthesis and release of
proinflammatory cytokines and cell integrity.
Bacterial strains and culture conditions.
A total of 15 invasive E. coli strains (LF strains) isolated from patients
with CD were tested, including the prototype AIEC strain LF82 of
serotype O83:H1, which was isolated from a chronic lesion of a patient
with CD (6). The strains were recovered from ileal biopsy
specimens from patients with chronic lesions who had been operated on
for CD (n = 7), from patients with early endoscopic
recurrent lesions at 3, 6, or 12 months postsurgery (n = 7), and from a patient without recurrence of CD up
to 2 years postsurgery (n = 1) (11).
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.9.5529-5537.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Adherent Invasive Escherichia coli Strains from
Patients with Crohn's Disease Survive and Replicate within
Macrophages without Inducing Host Cell Death
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
) than cells stimulated with 1 µg of
lipopolysaccharide (LPS)/ml. No release of interleukin-1
was
observed with LPS-prestimulated J774-A1 cells infected with AIEC LF82.
These findings showed that (i) AIEC strains are able to survive and to
replicate within macrophages, (ii) AIEC LF82 replication does not
induce any cell death of the infected cells, and (iii) LF82-infected
J774-A1 cells release high levels of TNF-
. These properties could be
related to some features of CD and particularly to granuloma formation,
one of the hallmarks of CD lesions.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
80°C and grown in Luria-Bertani (LB) broth without shaking, except S. flexneri M90T, which was cultured
in trypto-casein-soybean broth (TCS) with shaking overnight at 37°C.
Cell line and cell culture. The murine macrophage-like cell line J774-A1 (American Type Culture Collection no. TIB67) was maintained in an atmosphere containing 5% CO2 at 37°C in RPMI 1640 medium (Seromed, Biochrom KG, Berlin, Germany) supplemented with 10% (vol/vol) heat-inactivated fetal calf serum (FCS; Seromed), 1% L-glutamine (Life Technologies), 100,000 of penicillin/liter, 100 mg of streptomycin/liter, and 25 µg of amphotericin B/liter. J774-A1 cells were seeded in 24-well tissue culture plates (Polylabo, Strasbourg, France) at a density of 105 cells per cm2 and were grown for 18 h in an atmosphere containing 5% CO2 at 37°C.
Isolation and culture of murine peritoneal macrophages. Peritoneal cells were isolated by intraperitoneal (i.p.) injection of 5 ml of RPMI 1640 (Seromed) supplemented with 5% (vol/vol) heat-inactivated FCS (Seromed), 1% L-glutamine (Life Technologies), 100,000 U of penicillin/liter, 100 mg of streptomycin/liter, and 25 µg of amphotericin B/liter into OF1 mice (IFFA CREDO, Chatillon sur Chalaronne, France), that had been killed by cervical dislocation. Following i.p. injection, mice were shaken to dislodge peritoneal cells, and the lavage fluids were removed by syringe. The resulting cells, in the above-mentioned medium, were placed in 24-well tissue culture plates (Polylabo) at a density of 5 × 105 cells per well and maintained in an atmosphere containing 5% CO2 at 37°C. Two hours later, the medium was removed, and the plastic adherent cells were washed three times in 0.5 ml of phosphate-buffered saline (PBS; pH 7.2) and then incubated in 0.5 ml of complete RPMI medium as above at 37°C in a 5% CO2 incubator. Eighteen hours later, the culture medium was aspirated, and the cells were washed twice with PBS and then incubated with 0.5 ml of the above culture medium lacking antibiotics.
Isolation and culture of HMDM. Isolation of HMDM was performed as described by Libby et al. (27). Briefly, blood was collected from normal donors in heparinized syringes and in additional sterile glass tubes for use as autologous serum. Monocytes were purified by density gradient centrifugation using Isoprep and a differential adherence procedure with 2% gelatin-coated flasks. Nonadherent cells were removed by washes with RPMI, and adherent cells were eluted with RPMI plus 10 mM EDTA in PBS. The eluted cells were centrifuged and resuspended in RPMI containing 15% autologous serum. Monocytes were seeded into 24-well culture plates at a density of 5 × 105 cells per well. The monocytes were maintained in an atmosphere containing 5% CO2 at 37°C for 5 to 7 days until they differentiated into cells with characteristic macrophage morphology.
Bacterial survival and replication in macrophages. Bacterial uptake, survival, and replication were measured by the gentamicin protection assay. The MBC (concentration that reduced the bacterial count by 99.99%) of the antibiotic for all strains included in this study was determined in tissue culture medium, and the drug was used at 15- to 100-fold the MBC (the MBC ranged from 0.5 to 4 µg/ml)
Before infection, the cell monolayers were washed twice with PBS and the medium was replaced with 1 ml of RPMI 1640 supplemented with 10% heat-inactivated FCS. J774-A1 monolayers, murine peritoneal macrophages, and HMDM were infected at a multiplicity of infection (MOI) of 10 bacteria per macrophage. After a 2-h incubation at 37°C with 5% CO2, infected macrophages were washed twice with PBS, and fresh cell culture medium containing 100 µg of gentamicin/ml was added to kill extracellular bacteria. After incubation for an additional hour, the medium was removed and fresh medium containing 20 µg of gentamicin/ml was added for longer postinfection periods. To measure intracellular survival beyond 48 h postinfection, fresh cell culture medium containing gentamicin (20 µg/ml) was added daily to the infected cells. The number of internalized bacteria was determined in attached and detached cells. Attached cells were washed once with PBS, and 0.5 ml of 1% Triton X-100 (Sigma Chemical Company, St Louis, Mo.) in deionized water was placed in each well for 5 min to lyse the eukaryotic cells. This concentration of Triton X-100 had no effect on bacterial viability for at least 30 min. Samples were removed, diluted, and plated onto Mueller-Hinton agar plates to determine the number of CFU recovered from the lysed monolayers. To determine the number of bacteria in the detached cells, the culture medium was collected at each time point, centrifuged, washed in PBS, and treated with 1% Triton X-100 as described above. The number of bacteria surviving the gentamicin killing assay was determined after 1, 4, 8, 24, and 48 h of gentamicin treatment. Survival was expressed either as CFU per well or as the mean percentage of the number of bacteria recovered after 1 h postinfection, defined as 100%. In experiments with S. flexneri M90T or serovar Dublin SL2260, plates were centrifuged at 700 × g for 10 min after infection.Transmission electron microscopy (TEM). Cross sections of J774-A1 cells were prepared as follows. After infection, cells were fixed with 3% glutaraldehyde in 0.2 M cacodylate buffer at 4°C for 2 h and postfixed in 1% OsO4 in cacodylate buffer at 4°C for 1 h. After dehydration in a graded series of ethanol, the cultures were embedded in a 2-mm-thick Epon coating in the tissue culture well and polymerized for 3 days at 60°C. Suitable areas were oriented parallel to the cell layer surface on Epon blocks with an Epon mixture. Ultrathin sections were contrasted with uranyl acetate and lead citrate.
LDH activity.
J774-A1 cells were seeded in 24-well tissue
culture plates at a density of 2 × 105
cells/cm2 and grown for 18 h. They were then infected
at MOIs of 10 and 100, and processed as described above. Supernatants
of the infected macrophages were sampled at 1, 4, 8, and
24 h of gentamicin treatment, centrifuged at 2,500 × g for 3 min at 4°C, and assayed for lactate dehydrogenase (LDH)
activity. Enzymatic activity was determined in supernatants by using
NADH as a substrate (LDH kit; Boehringer, Mannheim, Germany). Release
of LDH was expressed as units per liter of supernatant. The percent
cytotoxicity was calculated as (experimental release
spontaneous release)/(total release
spontaneous release) × 100, where spontaneous release is the amount of LDH activity in
supernatants of cells incubated in medium alone and total release is
the LDH activity measured in macrophage lysates.
Annexin V binding and propidium iodide staining of infected macrophages. J774-A1 cells were seeded in 24-well tissue culture plates at a density of 2 × 105 cells per well. At various time points after infection at an MOI of 100 or after treatment with 5 µM gliotoxin (Sigma), cells and supernatant were harvested and stained with fluorescein isothiocyanate (FITC)-labeled annexin V and propidium iodide (annexin V-FITC apoptosis detection kit; Sigma) according to the supplier's protocol. With this protocol, live cells are not stained by either propidium iodide or annexin V-FITC. Cells which appear early in the apoptotic process are stained with annexin V-FITC alone, and necrotic cells are stained by both propidium iodide and annexin V-FITC. The percent stained cells was scored by analyzing 100 cells of three independent experiments in duplicate using a Zeiss fluorescence microscope.
DNA fragmentation. J774-A1 cells seeded at a density of 3.5 × 106 were infected for 2 h at an MOI of 100, as described above. After a 24-h gentamicin treatment, total genomic DNA was extracted from adherent and floating cells by a standard DNA extraction method (proteinase K and phenol-chloroform), ethanol precipitated, and incubated for 30 min in the presence of 1 µg of RNase (Boehringer)/ml. The DNA solution was analyzed by electrophoresis for 5 h in a 1.5% agarose-0.1% sodium dodecyl sulfate (SDS) gel and stained with ethidium bromide.
Detection of cytokines IL-1
and TNF-
in the supernatant of
infected macrophages.
Macrophages seeded at a density of
2 × 105 cells/cm2 were infected at an MOI
of 100, and supernatants were collected, centrifuged, and stored at
20°C. For interleukin-1
(IL-1
) only, cells were prestimulated
18 h before infection with 1 µg of E. coli O111:B4 lipopolysaccharide (LPS; Sigma)/ml. The amounts of murine cytokines IL-1
and tumor necrosis factor alpha (TNF-
) released in the culture supernatant or remaining in cells were determined by
enzyme-linked immunosorbent assay (ELISA) (Endogen Inc., Woburn,
Mass.). The optical density was determined at a wavelength of 450 nm,
and cytokine concentrations in picograms per milliliter were assessed according to the manufacturer's instructions.
| |
RESULTS |
|---|
|
|
|---|
Survival and replication of AIEC strains within the murine J774-A1
macrophage-like cell line.
In order to examine the
resistance of AIEC strains to the intracellular killing by
macrophages, murine J774-A1 macrophages were infected
with 15 AIEC strains. Unless otherwise stated, a 2-h infection at an
MOI of 10 was performed in all the experiments reported. The number of
intracellular bacteria surviving the gentamicin exposure was determined
after 1, 4, 8, 24, and 48 h of gentamicin treatment. Bacterial
uptake was quantified at 1 h postinfection and expressed as CFU
per well. Survival at 4, 8, 24, and 48 h postinfection was
expressed as mean percentages of the number of bacteria recovered after
1 h of gentamicin treatment, defined as 100% (Table
1).
|
|
Survival within murine resident peritoneal
macrophages.
Assays were performed at an MOI of 10 with
AIEC strain LF82, serovar Cholereasuis, and nonpathogenic E. coli K-12 C600. Results presented in Fig.
2 show only the intracellular behaviors
of AIEC strain LF82 and serovar Choleraesuis. We were unable to count any intracellular bacteria for E. coli K-12 at the
postinfection time points. Moreover, experiments performed at an MOI of
100 revealed that E. coli K-12 C600 was efficiently killed
as early as 4 h postinfection (data not shown), confirming the
very high bactericidal efficiency of these macrophages. The
number of serovar Choleraesuis intracellular bacteria recovered at 4 h
represented 34.1% of that recovered at 1 h. This dropped to 1.4%
at 8 h postinfection in the attached-macrophage
fraction. In the detached fraction, 16.0% of the initially
phagocytosed bacteria were counted at 8 h postinfection,
reflecting the Salmonella-induced apoptotic process. In
contrast, even though the number of AIEC LF82 bacteria decreased relative to the number initially internalized, 52.0% of the bacteria recovered at 1 h postinfection were also recovered at 4 h
postinfection. Hence, the number of live bacteria remained constant
over a period of 8 h postinfection and decreased to 14.2% at
24 h postinfection. Only very few bacteria were counted in the
detached cells over the postinfection time course.
|
Survival of AIEC strain LF82 within HMDM.
In order to confirm
the ability of AIEC to survive in human phagocytic cells, experiments
were conducted using the AIEC reference strain LF82 with HMDM. The
serovar Dublin strain SL2260, which is well characterized for its
behavior in HMDM, was included in our experiments for comparative
purposes. Detached and attached macrophage fractions were
cultured separately to enumerate intracellular bacteria. The results
are shown in Fig. 3. Results with serovar Dublin SL2260 were in accordance with already published data
(27). The number of CFU recovered after infection with
serovar Dublin SL2260 increased slightly in the attached
macrophages over 24 h and reached 122% of the number of
bacteria recovered after 1 h postinfection, taken as 100%.
Bacteria in detached macrophages were observed as early as
4 h postinfection, and their number increased over the
postinfection period. The number of bacteria in the attached fraction
of AIEC LF82-infected macrophages increased over 4 h
postinfection to reach 208% of the initially internalized bacteria and
decreased slightly over 48 h postinfection. However, at 48 h,
the percent intracellular bacteria still represented 96% of the
bacteria recovered after 1 h of gentamicin treatment. In contrast
to serovar Dublin-infected macrophages, no bacteria were
recovered in the corresponding detached fractions, confirming the
lack of cytotoxicity induced by AIEC LF82 infection of J774-A1 macrophages. With the nonpathogenic strain K-12 C600, a
decrease in the number of viable bacteria was observed as early as
4 h postinfection and only 5% of the bacteria initially
internalized were still alive after 24 h postinfection.
|
AIEC strain LF82 did not induce cell death of J774-A1 infected
macrophages.
All experiments to analyze the cell integrity
of infected macrophages were performed at MOIs of 10 and 100, to check whether a higher number of internalized bacteria was able to
induce cell death. The culture supernatants of infected or noninfected
macrophages were assayed for the presence of the cytoplasmic
enzyme LDH to estimate the membrane integrity of the cells. Samples of
the culture medium were tested at 1, 4, 8, and 24 h postinfection
(Table 2). S. flexneri
M90T and serovar Choleraesuis were included as positive controls, since
they are known to induce cell death (30, 42). E. coli K-12 C600 was used as a negative control. The amounts of LDH
released were expressed as LDH activity recovered in the supernatant or
as a percentage relative to that obtained at 1 h.
|
B
inhibitor gliotoxin 5 µM, were used as positive controls (30,
39, 42). Results, expressed as percentages of apoptotic and
necrotic cells, are presented in Table 3.
Infection with S. flexneri, infection with serovar
Cholerasuis, and treatment with gliotoxin for 8 h all induced
apoptosis, since the percentages of macrophages exhibiting redistribution of phosphatidylserine to the cell surface were 26.6, 25.0, and 36.6%, respectively. At 8 or 24 h after infection with
either AIEC LF82 or K-12 C600, the percentage of macrophages labeled with annexin V-FITC was similar to that obtained with untreated
cells, and very few necrotic cells were enumerated.
|
|
AIEC LF82 induced spacious phagosomes.
Morphological data to
confirm the survival and replication abilities of AIEC LF82 within
J774-A1 cells were obtained with TEM. One hour after infection, LF82
bacteria were observed in small vacuoles (Fig.
5A). LF82-infected cells exhibited larger phagosomes at 8 h, some of which were observed to fuse, leading to
the formation of spacious phagosomes (Fig. 5B). At 24 h
postinfection, infected macrophages showed a particularly
prominent vacuole containing numerous bacteria. None of the
internalized bacteria were free in the cytoplasm. The phagosomes
occupied most of the cytoplasmic compartment and did not seem to alter
the morphology of the nucleus or that of the cytoplasmic membrane (Fig.
5C). There was no morphological evidence of cytotoxicity, confirming
the results of LDH release and DNA analysis. Despite this large number
of intracellular bacteria, infected macrophages appeared viable
even after 48 h postinfection (data not shown). In contrast, after
24 h, macrophages with internalized E. coli K-12
C600 harbored only a few phagosomes and also had small, round vesicular
structures in phagosome vacuoles that appeared to represent fragments
of organisms (data not shown). Thus, AIEC LF82 can persist within
phagocytic cells for a long period in a large vacuole without
inducing any apparent cell death or damage to the infected
macrophages.
|
AIEC LF82 induced secretion by macrophages of TNF-
but
no IL-1
release.
To explore the possible mechanisms in an
inflammatory response induced by AIEC LF82, we examined its ability to
induce (IL-1
) release and TNF-
secretion by ELISA.
release presented in Table
4 was obtained with macrophages
prestimulated with LPS overnight and then infected with S. flexneri or AIEC LF82 at an MOI of 100. After 1 h of
gentamicin treatment, the uninfected cell lysate gave an IL-1
concentration of 97 pg/ml, and the concentration of IL-1
in the
supernatant of uninfected cells was less than 10 pg/ml at 1 and 24 h
postinfection. As expected, S. flexneri M90T induced a
high release of mature IL-1
at 1 h postinfection (40.5 pg/ml
recovered in the supernatant). This result was in accordance with
previously published findings showing that IL-1
is released when the
cells undergo apoptosis (15, 41). In contrast, AIEC LF82
induced no detectable release of IL-1
, even after 24 h of
gentamicin treatment.
|
secretion was done with J774-A1 cells
infected with AIEC LF82 at an MOI of 100 in comparison with LPS-treated
cells (Table 4). Small amounts of TNF-
found in the supernatant of
AIEC LF82-infected or LPS-stimulated cells at 1 h postinfection.
At 24 h postinfection, a maximum amount of TNF-
, 1,300 pg/ml,
was recovered in the supernatant of cells stimulated with 1 µg of
LPS/ml. In comparison, AIEC LF82-infected J774-A1 cells secreted a very
high level of TNF-
: 3,533 pg/ml was recovered in the culture medium
at 24 h postinfection.
| |
DISCUSSION |
|---|
|
|
|---|
The search for infectious agents as a possible cause of CD has mainly focused on intracellular pathogens which have evolved to resist phagocytosis and often persist for long periods within macrophages leading to chronic antigenic stimulation and T-cell and macrophage activation. This results in the formation of granulomas surrounding the microbes. Granulomatous inflammation is not only a histologic hallmark of infections with some intracellular bacteria and fungi but also a characteristic feature of CD, with granulomas found in the bowel wall and in regional lymph nodes (12). Moreover the presence of specific E. coli antigens was previously found in macrophages distributed within the lamina propria, in granulomas, and in the germinal centers of mesenteric lymph nodes in patients with CD (9, 28). We previously reported that the ileal mucosa of patients with CD is abnormally colonized by pathogenic E. coli strains termed AIEC, which have the ability to adhere to and invade epithelial intestinal cultured cells (6, 11). The aim of the present work was to determine the intramacrophagic fate of AIEC strains isolated from patients with CD and the behavior of the infected macrophages in order to evaluate the ability of such invasive bacteria to participate in granuloma formation.
We showed in the present study that all the AIEC strains that we isolated from patients with CD were able to survive and to replicate extensively within J774-A1 phagocytic cells. After 48 h postinfection, the number of intracellular AIEC bacteria increased 2.2- to 74.2-fold over the number at initial infection, depending on the AIEC strains studied. Moreover, the AIEC strain LF82 was able to persist efficiently until 5 days postinfection within J774-A1 macrophages. No detached cells, no LDH release, no annexin V-FITC binding, and no sign of DNA fragmentation or degradation were observed with J774-A1 infected cells even after 24 h postinfection, indicating that there was no cell death. The behavior of the AIEC strains within macrophages is different from that of other invasive bacteria, since most of them induce cell death of the infected macrophages (for a review see reference 31). Through cell death, infected macrophages attempt to both prevent the spread of intracellular pathogens and elicit a potent antibacterial immune response via the release of proinflammatory cytokines.
Comparative studies of intracellular survival of AIEC LF82 within two cell models indicated that this strain had a survival advantage in HMBM in comparison with murine peritoneal macrophages. However, in comparison to published data concerning the intracellular resistance of various Salmonella serovars or Shigella within murine peritoneal macrophages at early postinfection times before induction of macrophage cell death, the fraction of AIEC LF82 resistant to bactericidal killing was similar or higher, depending on the strain (2, 8, 19, 20, 22, 34). In the same way, the survival of intracellular AIEC LF82 within HMDM was similar to or even higher than those previously reported for human-pathogenic Salmonella serovars or Shigella (2, 15, 22, 27, 35, 36, 38). However, a great difference was observed between Salmonella- or Shigella- and AIEC LF82-infected macrophages. No detached cells corresponding to dead cells were observed with AIEC LF82-infected cells, even after 24 or 48 h postinfection.
Strain LF82 does not induce any cell death of the infected
macrophages. To our knowledge, this is the first report
describing the ability of E. coli strains to replicate
extensively within macrophages without inducing cell membrane
damage or cell death within a 24-h period. Indeed, the ability to
induce macrophage cell death is a common feature of most of the
diarrheagenic E. coli strains. Members of all the
diarrheagenic pathovars of human E. coli studied so far
(enteroaggregative E. coli, enterohemorrhagic E. coli, EIEC, EPEC, ETEC, and diffusely adhering E. coli)
were cytotoxic to J774-A1 after 24 h of infection at an MOI of 10 or 100 (24, 25). Except for the ETEC strain H10407, for
which the cell death induced has not been elucidated, all the different E. coli pathovars induce cell death via an apoptotic
mechanism (25). Infection of HMDM and J774-A1 murine
macrophages with several enteroaggregative and
cytodetaching E. coli strains demonstrated that these
strains were not able to replicate intracellularly and induced
macrophage cell death accompanied by LDH and IL-1
release
into the culture supernatant (14). Moreover, assays performed with a few invasive E. coli strains that we
isolated from stools of healthy controls indicated that these strains
were not resistant to macrophage killing within the
J774-A1 cells (data not shown). Thus, invasive E. coli
strains isolated from CD lesions, which possess none of the known
genetic invasive determinants of E. coli, Shigella, or
Salmonella, share a virulence factor(s) which confers on the
bacteria the ability to evade the bactericidal pathways to which
intracellular bacteria are normally exposed within macrophages.
The mechanism by which AIEC strains resist bacterial killing by macrophages is still under investigation. Pathogens that survive within host phagocytes have various mechanisms of survival: (i) by avoiding phagocytosis (13, 17), (ii) by inhibiting fusion of bacteria-containing phagosomes with lysosomes and endosomes (3), (iii) by remodeling their phagosome (10), (iv) by moving out of the phagosome (21, 23), or (v) by resisting the antimicrobial environment of the mature phagolysosome (4).
LF82 bacterial replication does not require bacterial escape into the cytoplasmic compartment, in contrast to its behavior within intestinal epithelial cells (6). Within J774-A1 macrophages, the bacteria induced the formation of a single spacious vacuole by fusion of initial phagosomes. Such large vacuoles containing numerous bacteria have also been observed with J774-A1 cells infected with Salmonella or Yersinia enterocolitica clinical isolates (2, 3, 18). The formation of this specific compartment induced by AIEC LF82 within the infected macrophages is probably the key to its ability to resist macrophage killing. Spacious-phagosome formation may promote LF82 survival by dilution of toxic lysosomal compounds or attenuation of antimicrobial factors, including decreased phagosomal acidification.
It is noteworthy that AIEC strains are able to invade intestinal epithelial cells by a macropinocytosis-like process requiring actin polymerization and recruitment of microtubules and by inducing host cell membrane elongations at the sites of contact with epithelial cells. Type 1 pili were shown to play an essential role in promoting AIEC LF82 internalization within intestinal epithelial cells (5). We thought that they were also involved in stimulating the entry of bacteria into macrophages, and possibly subsequent resistance. Preliminary experiments already performed showed that all type 1 pilus-negative mutants, and the AIEC LF82 wild-type strain in the presence of 2% D-mannose, were able to survive and replicate intracellularly as efficiently as the wild-type LF82. The mechanism of entry, which may involve a specific phagosome formation with an unusual endocytic trafficking as described for Salmonella-infected macrophages (3, 30, 34), is currently under investigation.
We addressed the question of whether LF82-infected macrophages
released IL-1
or TNF-
, both capable of mediating an inflammatory process. No IL-1
was released even after 24 h post-AIEC LF82 infection. This result was not surprising, since it has been shown that
this proinflammatory cytokine was only released in the culture medium during apoptosis of S. flexneri-infected
macrophages (41). Compared to LPS-stimulated
macrophages, a high level of TNF-
was secreted after 24 h of infection with AIEC LF82. As TNF-
is transcribed and translated
de novo after macrophage stimulation, the synthesis of this
cytokine demonstrated that macrophages were still active even
with numerous intracellular bacteria. Moreover, proinflammatory TNF-
secretion reflects an activation of infected macrophages. We
can speculate that such AIEC-infected macrophages are
continuously activated by the sustained presence of intracellular bacteria resistant for a long period to the bacterial killing.
In conclusion, AIEC strains, which are able to invade intestinal epithelial cells, are also able to trigger uptake into and survival within macrophages without inducing host cell death. These properties could allow the bacteria to translocate across the human intestinal barrier, to move to deep tissues, to continuously activate macrophages, and to potentially induce the formation of granulomas, one of the hallmarks of CD lesions.
| |
ACKNOWLEDGMENTS |
|---|
This study was supported by grants from Association F. Aupetit, Institut de Recherche des Maladies de l'Appareil Digestif (IRMAD, Laboratories Astra France), and the Ministère de la Recherche et de la Technologie (EA2148). N. Barnich was supported by a grant from Association F. Aupetit.
We are grateful to Christel Neut of the Laboratoire de
Bactériologie, Faculté de Pharmacie, Lille, France for
providing E. coli strains isolated from patients with CD and
for helpful discussions. We also thank Annie Fraisse, Monique Orion,
and Josiane Payen of the Electron Microscopy Department of Michel
Bourges for technical assistance. We thank Philippe Sansonetti,
Institut Pasteur, Paris, France, for providing S. flexneri
M90T. We gratefully thank Donald Guiney, La Jolla School of Medicine at
the University of California
San Diego, for providing
Salmonella serovar Dublin strain SL2260 and for valuable
help in preparing HMDM. We also thank Herbert J. Van Kruiningen and
Cecilia Berin for helpful discussions and critical reading of the manuscript.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Pathogénie Bactérienne Intestinale, Laboratoire de Bactériologie, Faculté de Pharmacie, 63001 Clermont-Ferrand, France. Phone: 33 4 73 17 79 97. Fax: 33 4 73 27 74 94. E-mail: arlette.darfeuille-michaud{at}u-clermont1.fr.
Editor: E. I. Tuomanen
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Aderem, A., and D. M. Underhill. 1999. Mechanisms of phagocytosis in macrophages. Annu. Rev. Immunol. 17:593-623[CrossRef][Medline]. |
| 2. | Alpuche-Aranda, C. M., E. P. Berthiaume, B. Mock, J. A. Swanson, and S. I. Miller. 1995. Spacious phagosome formation within mouse macrophages correlates with Salmonella serotype pathogenicity and host susceptibility. Infect. Immun. 63:4456-4462[Abstract]. |
| 3. |
Alpuche-Aranda, C. M.,
E. L. Racoosin,
J. A. Swanson, and S. I. Miller.
1994.
Salmonella stimulate macrophage macropinocytosis and persist within spacious phagosomes.
J. Exp. Med.
179:601-608 |
| 4. | Baca, O. G., Y. P. Li, and H. Kumar. 1994. Survival of the Q fever agent Coxiella burnetii in the phagolysosome. Trends Microbiol. 2:476-480[CrossRef][Medline]. |
| 5. | Boudeau, J., N. Barnich, and A. Darfeuille-Michaud. 2001. Type 1 pili-mediated adherence of Escherichia coli strain LF82 isolated from Crohn's disease is involved in bacterial invasion of intestinal epithelial cells. Mol. Microbiol. 39:1272-1284[CrossRef][Medline]. |
| 6. |
Boudeau, J.,
A. L. Glasser,
E. Masseret,
B. Joly, and A. Darfeuille-Michaud.
1999.
Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease.
Infect. Immun.
67:4499-4509 |
| 7. | Boudeau, J., A. L. Glasser, C. Neut, P. Desreumaux, A. Cortot, C. Rich, B. Joly, J. F. Colombel, and A. Darfeuille-Michaud. 2000. Invasive ability of Escherichia coli strains isolated from ileal mucosa in Crohn's disease. Gastroenterology 118:A1847. |
| 8. |
Buchmeier, N. A., and F. Heffron.
1989.
Intracellular survival of wild-type Salmonella typhimurium and macrophage-sensitive mutants in diverse populations of macrophages.
Infect. Immun.
57:1-7 |
| 9. | Cartun, R. W., H. J. Van Kruiningen, C. A. Pedersen, and M. M. Berman. 1993. An immunocytochemical search for infectious agents in Crohn's disease. Mod. Pathol. 6:212-219[Medline]. |
| 10. | Clemens, D. L. 1996. Characterization of the Mycobacterium tuberculosis phagosome. Trends Microbiol. 4:113-118[CrossRef][Medline]. |
| 11. | Darfeuille-Michaud, A., C. Neut, N. Barnich, E. Lederman, P. Di Martino, P. Desreumaux, L. Gambiez, B. Joly, A. Cortot, and J. F. Colombel. 1998. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology 115:1405-1413[CrossRef][Medline]. |
| 12. | Duchmann, R., and M. Zeitz. 1999. Crohn's disease, p. 1055-1080. In P. L. Ogra, et al. (ed.), Mucosal immunology, 2nd ed. Academic Press, San Diego, Calif. |
| 13. | Ernst, J. D. 2000. Bacterial inhibition of phagocytosis. Cell Microbiol. 2:379-386[CrossRef][Medline]. |
| 14. |
Fernandez-Prada, C.,
B. D. Tall,
S. E. Elliott,
D. L. Hoover,
J. P. Nataro, and M. M. Venkatesan.
1998.
Hemolysin-positive enteroaggregative and cell-detaching Escherichia coli strains cause oncosis of human monocyte-derived macrophages and apoptosis of murine J774 cells.
Infect. Immun.
66:3918-3924 |
| 15. | Fernandez-Prada, C. M., D. L. Hoover, B. D. Tall, and M. M. Venkatesan. 1997. Human monocyte-derived macrophages infected with virulent Shigella flexneri in vitro undergo a rapid cytolytic event similar to oncosis but not apoptosis. Infect. Immun. 65:1486-1496[Abstract]. |
| 16. |
Finlay, B. B., and P. Cossart.
1997.
Exploitation of mammalian host cell functions by bacterial pathogens.
Science
276:718-725 |
| 17. |
Goosney, D. L.,
J. Celli,
B. Kenny, and B. B. Finlay.
1999.
Enteropathogenic Escherichia coli inhibits phagocytosis.
Infect. Immun.
67:490-495 |
| 18. |
Grant, T.,
V. Bennett-Wood, and R. M. Robins-Browne.
1999.
Characterization of the interaction between Yersinia enterocolitica biotype 1A and phagocytes and epithelial cells in vitro.
Infect. Immun.
67:4367-4375 |
| 19. | Guilloteau, L. A., T. S. Wallis, A. V. Gautier, S. MacIntyre, D. J. Platt, and A. J. Lax. 1996. The Salmonella virulence plasmid enhances Salmonella-induced lysis of macrophages and influences inflammatory responses. Infect. Immun. 64:3385-3393[Abstract]. |
| 20. | Haque, M. A., S. Yoshino, K. Ohki, S. Inada, and O. Kohashi. 1996. Effect of growth condition on in-vitro susceptibility of Shigella dysenteriae type one killing by murine peritoneal macrophages. J. Med. Microbiol. 44:99-104[Abstract]. |
| 21. | High, N., J. Mounier, M. C. Prevost, and P. J. Sansonetti. 1992. IpaB of Shigella flexneri causes entry into epithelial cells and escape from the phagocytic vacuole. EMBO J. 11:1991-1999[Medline]. |
| 22. | Ishibashi, Y., and T. Arai. 1996. A possible mechanism for host-specific pathogenesis of Salmonella serovars. Microb. Pathog. 21:435-446[CrossRef][Medline]. |
| 23. | Jones, S., K. Preiter, and D. A. Portnoy. 1996. Conversion of an extracellular cytolysin into a phagosome-specific lysin which supports the growth of an intracellular pathogen. Mol. Microbiol. 21:1219-1225[CrossRef][Medline]. |
| 24. |
Lai, X. H.,
S. Y. Wang, and B. E. Uhlin.
1999.
Expression of cytotoxicity by potential pathogens in the standard Escherichia coli collection of reference (ECOR) strains.
Microbiology
145:3295-3303 |
| 25. | Lai, X. H., J. G. Xu, S. Melgar, and B. E. Uhlin. 1999. An apoptotic response by J774 macrophage cells is common upon infection with diarrheagenic Escherichia coli. FEMS Microbiol. Lett. 172:29-34[CrossRef][Medline]. |
| 26. | Libby, S. J., L. G. Adams, T. A. Ficht, C. Allen, H. A. Whitford, N. A. Buchmeier, S. Bossie, and D. G. Guiney. 1997. The spv genes on the Salmonella dublin virulence plasmid are required for severe enteritis and systemic infection in the natural host. Infect. Immun. 65:1786-1792[Abstract]. |
| 27. | Libby, S. J., M. Lesnick, P. Hasegawa, E. Weidenhammer, and D. G. Guiney. 2000. The Salmonella virulence plasmid spv genes are required for cytopathology in human monocyte-derived macrophages. Cell Microbiol. 2:49-58[CrossRef][Medline]. |
| 28. | Liu, Y., H. J. Van Kruiningen, A. B. West, R. W. Cartun, A. Cortot, and J. F. Colombel. 1995. Immunocytochemical evidence of Listeria, Escherichia coli, and Streptococcus antigens in Crohn's disease. Gastroenterology 108:1396-1404[CrossRef][Medline]. |
| 29. |
Masseret, E.,
J. Boudeau,
J. F. Colombel,
C. Neut,
P. Desreumaux,
B. Joly,
A. Cortot, and A. Darfeuille-Michaud.
2001.
Genetically related Escherichia coli strains associated with Crohn's disease.
Gut
48:320-325 |
| 30. |
Monack, D. M.,
B. Raupach,
A. E. Hromockyj, and S. Falkow.
1996.
Salmonella typhimurium invasion induces apoptosis in infected macrophages.
Proc. Natl. Acad. Sci. USA
93:9833-9388 |
| 31. | Navarre, W. W., and A. Zychlinsky. 2000. Pathogen-induced apoptosis of macrophages: a common end for different pathogenic strategies. Cell Microbiol. 2:265-273[CrossRef][Medline]. |
| 32. |
Sansonetti, P. J.,
D. J. Kopecko, and S. B. Formal.
1982.
Involvement of a plasmid in the invasive ability of Shigella flexneri.
Infect. Immun.
35:852-860 |
| 33. | Sansonetti, P. J., G. Tran Van Nhieu, and C. Egile. 1999. Rupture of the intestinal epithelial barrier and mucosal invasion by Shigella flexneri. Clin. Infect. Dis. 28:466-475[Medline]. |
| 34. |
Schwan, W. R.,
X. Z. Huang,
L. Hu, and D. J. Kopecko.
2000.
Differential bacterial survival, replication, and apoptosis-inducing ability of Salmonella serovars within human and murine macrophages.
Infect. Immun.
68:1005-1013 |
| 35. | Schwan, W. R., and D. J. Kopecko. 1997. Serovar-specific differences in Salmonella survival within macrophage cells. Adv. Exp. Med. Biol. 412:277-278[Medline]. |
| 36. | Sizemore, D. R., E. A. Elsinghorst, L. C. Eck, A. A. Branstrom, D. L. Hoover, R. L. Warren, and F. A. Rubin. 1997. Interaction of Salmonella typhi strains with cultured human monocyte-derived macrophages. Infect. Immun. 65:309-312[Abstract]. |
| 37. |
Tanner, A. R.,
M. J. Arthur, and R. Wright.
1984.
Macrophage activation, chronic inflammation and gastrointestinal disease.
Gut
25:760-783 |
| 38. | Vladoianu, I. R., H. R. Chang, and J. C. Pechere. 1990. Expression of host resistance to Salmonella typhi and Salmonella typhimurium: bacterial survival within macrophages of murine and human origin. Microb. Pathog. 8:83-90[CrossRef][Medline]. |
| 39. |
Waring, P.,
R. D. Eichner,
A. Mullbacher, and A. Sjaarda.
1988.
Gliotoxin induces apoptosis in macrophages unrelated to its antiphagocytic properties.
J. Biol. Chem.
263:18493-18499 |
| 40. | Zumla, A., and D. G. James. 1996. Granulomatous infections: etiology and classification. Clin. Infect. Dis. 23:146-158[Medline]. |
| 41. | Zychlinsky, A., C. Fitting, J. M. Cavaillon, and P. J. Sansonetti. 1994. Interleukin 1 is released by murine macrophages during apoptosis induced by Shigella flexneri. J. Clin. Investig. 94:1328-1332. |
| 42. | Zychlinsky, A., M. C. Prevost, and P. J. Sansonetti. 1992. Shigella flexneri induces apoptosis in infected macrophages. Nature 358:167-169[CrossRef][Medline]. |
This article has been cited by other articles:
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||